ISBN:
9783642292651
Language:
English
Pages:
Online-Ressource (XXIII, 457 p. 30 illus., 12 illus. in color, digital)
Series Statement:
SpringerLink
Series Statement:
Bücher
Parallel Title:
Buchausg. u.d.T. Patenting nanomedicines
Keywords:
Medicine
;
Philosophy of law
;
medicine Philosophy
;
Law
;
Law
;
Medicine
;
Philosophy of law
;
medicine Philosophy
;
Aufsatzsammlung
;
Targeted drug delivery
;
Nanopartikel
;
Patentschutz
Abstract:
[Publisher-supplied data] Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities focusses on the fundamental aspects of Patenting Nanomedicines applied in different Drug Delivery and Targeting Systems. The promoters of new findings in this field of research are numerous and spread worldwide; therefore, managing intellectual property portfolios, and the acquisition and exploitation of new knowledge face several contingency factors. Today, the scientific community is discussing issues of economic outcomes in the field of Nanomedicines. Major concerns include questions as to whether the research groups, academics, industry and other stakeholders should work in unison or independently, if innovation or adaptation of new technology should be prioritized, public versus private research funding, and safeguarding versus sharing knowledge. However, despite its increasing importance for humankind, it is a matter of concern as to whether technological development can really be stimulated by patent protection. An intellectual property strategy should aim to develop a qualitative patent portfolio for continuous learning. This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts Part I is composed of the first 3 chapters, which focus on the fundamentals of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas Part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting. An outstanding team of 53 authors have contributed to this book, which will be of interest to professionals from the field of patent examiners, academics, researchers and scientists, students and other practitioners
Abstract:
"Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities focusses on the fundamental aspects of Patenting Nanomedicines applied in different "Drug Delivery and Targeting Systems. The promoters of new findings in this field of research are numerous and spread worldwide; therefore, managing intellectual property portfolios, and the acquisition and exploitation of new knowledge face several contingency factors. Today, the scientific community is discussing issues of economic outcomes in the field of Nanomedicines. Major concerns include questions as to whether the research groups, academics, industry and other stakeholders should work in unison or independently, if innovation or adaptation of new technology should be prioritized, public versus private research funding, and safeguarding versus sharing knowledge. However, despite its increasing importance for humankind, it is a matter of concern as to whether technological development can really be stimulated by patent protection. An intellectual property strategy should aim to develop a qualitative patent portfolio for continuous learning.This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts Part I is composed of the first 3 chapters, which focus on the "fundamentals of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas Part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting. An outstanding team of 53 authors have contributed to this book, which will be of interest to professionals from the field of patent examiners, academics, researchers and scientists, students and other practitioners.
Description / Table of Contents:
Patenting Nanomedicines; Legal Aspects, Intellectual Propertyand Grant Opportunities; Preface; Editor's Note to Readers; Contents; Contributors; Abbreviations; Part I: Fundamentals; Chapter 1: Intellectual Property and Nanopharmaceuticals; 1.1 Introduction; 1.1.1 Nanomedicine and Nanopharmaceuticals: Definitions and Attributes; 1.1.2 Nanopharmaceuticals Landscape; 1.1.3 Marketed Nanopharmaceuticals; 1.2 Nanopharmaceuticals: What Can Be Patented?; 1.2.1 Patentability Criteria: USPTO and EPO; 1.2.2 Features of Nanopharmaceuticals Patent Claims
Description / Table of Contents:
1.3 Nanomedicine Startups and Intellectual Property1.4 Intellectual Property Licensing; 1.4.1 Licensing Agreements of Intellectual Property; 1.4.2 Technology Protection and Compulsory Licensing; 1.4.3 University-Industry Collaboration; 1.4.4 The Doctrine of Bayh Dole Act; 1.4.5 The Bayh-Dole Act and Nanopharmaceuticals; 1.5 Patent Land Seize; 1.6 Intellectual Property: Financial Features; 1.7 Challenges in Nanopharmaceuticals Patenting; 1.8 Conclusions; References; Chapter 2: Challenges and Emerging Issues in Patenting Nanomedicines; 2.1 Introduction; 2.2 Definition and Scope of Nanomedicine
Description / Table of Contents:
2.3 Nanotechnology and Nanomedicine2.4 Patents and Patenting; 2.4.1 Searching Nanomedicine Related Patent; 2.4.1.1 Patent Search Domain; 2.4.1.2 Criteria for Patentability of Nanomedicine; 2.5 Problems of Commercialization; 2.5.1 Role of Patent on Nanomedicine Commercialization; 2.6 Areas of Patenting in Nanomedicine; 2.6.1 Nanomaterials; 2.6.2 Medical Devices; 2.6.3 Medicinal Products; 2.6.4 Nanomedicines; 2.7 Nanomedicine Based New Delivery Systems; 2.7.1 Patenting Solid Nanoparticulate Drug; 2.8 Role of Pharmaceutical Industry in Nanomedicine Patenting
Description / Table of Contents:
2.9 Emerging Issues in Nanomedicine Patents2.10 Challenges in Patenting Nanomedicine; 2.10.1 Technical Challenges; 2.10.2 Legal Challenges; 2.10.3 Regulatory Challenges; 2.10.4 Thickets of Overlapping Patents; 2.10.5 Environmental and Safety Challenges; 2.10.6 Ethical Challenges; 2.11 Promise of Nanomedicine; 2.11.1 Bioresorbable Materials; 2.11.2 Tissue Engineering; 2.12 Nanomedicine and Ethics; 2.12.1 Ethics, Governance and Policies; 2.13 Conclusions; References; Chapter 3: Legislative Measures for In Vitro-In Vivo Correlations and Pharmacokinetic Modeling; 3.1 Introduction
Description / Table of Contents:
3.1.1 The Rise of Nanotechnology and Defining Nanopharmaceuticals3.1.2 Complexities and Issues Regarding Patenting of Nanopharmaceuticals; 3.1.3 Overview of Factors That Impact on the Pharmacokinetics of Nanopharmaceuticals Affecting the Market Exclusivity of a Patented Delivery System; 3.1.3.1 Nanoparticle Diameter; 3.1.3.2 Surface Modification with Polyethylene Glycol; 3.1.3.3 Surface Modification with Targeting Ligands or Functionalization with Drug; 3.1.3.4 Nanoparticle Charge; 3.1.3.5 Pharmacokinetics of Polymersomes Having a Worm-Shaped Architecture
Description / Table of Contents:
3.2 Working Definition and Categorization of an IVIVC
Note:
Description based upon print version of record
DOI:
10.1007/978-3-642-29265-1
URL:
Volltext
(lizenzpflichtig)
Permalink
